Hicham Skali, MD, MSc
Hicham Skali, MD, MSc
Brigham and Women's Hospital
Verifierad e-postadress på post.harvard.edu
Citeras av
Citeras av
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
SD Solomon, N Anavekar, H Skali, JJV McMurray, K Swedberg, S Yusuf, ...
Circulation 112 (24), 3738-3744, 2005
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction
LAM Zornoff, H Skali, MA Pfeffer, M St. John Sutton, JL Rouleau, ...
Journal of the American College of Cardiology 39 (9), 1450-1455, 2002
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis
H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ...
Journal of clinical Oncology 32 (22), 2380, 2014
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis
R Blankstein, M Osborne, M Naya, A Waller, CK Kim, VL Murthy, ...
Journal of the American College of Cardiology 63 (4), 329-336, 2014
Two‐Dimensional Assessment of Right Ventricular Function: An Echocardiographic–MRI Correlative Study
NS Anavekar, D Gerson, H Skali, RY Kwong, E Kent Yucel, SD Solomon
Echocardiography 24 (5), 452-456, 2007
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM …
S Kenchaiah, SJ Pocock, D Wang, PV Finn, LAM Zornoff, H Skali, ...
Circulation 116 (6), 627-636, 2007
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
SD Solomon, H Skali, NS Anavekar, M Bourgoun, S Barvik, JK Ghali, ...
Circulation 111 (25), 3411-3419, 2005
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
A Verma, A Meris, H Skali, JK Ghali, JMO Arnold, M Bourgoun, ...
JACC: Cardiovascular Imaging 1 (5), 582-591, 2008
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
SD Solomon, D Wang, P Finn, H Skali, L Zornoff, JJV McMurray, ...
Circulation 110 (15), 2180-2183, 2004
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
D Aguilar, SD Solomon, L Køber, JL Rouleau, H Skali, JJV McMurray, ...
Circulation 110 (12), 1572-1578, 2004
Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction
P Jose, H Skali, N Anavekar, C Tomson, HM Krumholz, JL Rouleau, ...
Journal of the American Society of Nephrology 17 (10), 2886-2891, 2006
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)
NS Anavekar, H Skali, M Bourgoun, JK Ghali, L Kober, AP Maggioni, ...
The American journal of cardiology 101 (5), 607-612, 2008
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement …
MP Tokmakova, H Skali, S Kenchaiah, E Braunwald, JL Rouleau, ...
Circulation 110 (24), 3667-3673, 2004
Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients …
MT Osborne, EA Hulten, A Singh, AH Waller, MS Bittencourt, GC Stewart, ...
Journal of Nuclear Cardiology 21, 166-174, 2014
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
AC Pouleur, E Barkoudah, H Uno, H Skali, PV Finn, SL Zelenkofske, ...
Circulation 122 (6), 597-602, 2010
Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism
T Scridon, C Scridon, H Skali, A Alvarez, SZ Goldhaber, SD Solomon
The American journal of cardiology 96 (2), 303-305, 2005
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction
AM Murcia, CH Hennekens, GA Lamas, M Jiménez-Navarro, JL Rouleau, ...
Archives of internal medicine 164 (20), 2273-2279, 2004
Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis
T Vita, DR Okada, M Veillet-Chowdhury, PE Bravo, E Mullins, E Hulten, ...
Circulation: Cardiovascular Imaging 11 (1), e007030, 2018
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction …
D Castagno, H Skali, M Takeuchi, K Swedberg, S Yusuf, CB Granger, ...
Journal of the American College of Cardiology 59 (20), 1785-1795, 2012
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation
MT Osborne, EA Hulten, VL Murthy, H Skali, VR Taqueti, S Dorbala, ...
Journal of Nuclear Cardiology 24 (1), 86-99, 2017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20